Dacarbazine, Nimustine Hydrochloride, Cisplatin and Tamoxifen Combination Chemotherapy for Advanced Malignant Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 8, 1999-08 ,pp. : 489-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

Coping with melanoma‐related worry: a qualitative study of the experiences and support needs of patients with malignant melanoma

By  

JOURNAL OF CLINICAL NURSING, Vol. 24, Iss. 7-8, 2015-04 ,pp. : 937-947

John Wiley & Sons Inc

Access to resources Recommend Favorite

HOST‐TUMOR ANTAGONISM. XV. THE APPARENTLY BENEFICIAL EFFECTS OF ACUTE CONCURRENT INFECTIONS OR OF TOXIN THERAPY ON THE COURSE OF MALIGNANT MELANOMA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 8, Iss. 5, 1960-05 ,pp. : 378-397

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of tuberculosis in patients treated with anti‐tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 3, 2015-03 ,pp. : 323-330

John Wiley & Sons Inc

Access to resources Recommend Favorite